✨ Innovation alert: CellEKT, developed by the lab of Oncode Investigator Mario van der Stelt & Oncode Researcher Joel Rüegger (both at @unileiden.bsky.social ), uses advanced probes to profile kinase inhibitor selectivity, supporting safer, targeted cancer therapies. Read more: lnkd.in/gxCBtu7W
22.05.2025 09:55
👍 1
🔁 0
💬 0
📌 0
€3M in funding for rare cancer therapies — REACT-NL call is now open! Oncode Institute, KWF Kankerbestrijding, and KiKa launch REACT-NL under Health~Holland 2025 PPP.
👉 €3M funding
👉 Deadline: Sept 2025
👉 Eligible: Dutch public-private consortia
Read more:
oncodeinstitute.nl/news/react-n...
14.05.2025 13:14
👍 2
🔁 0
💬 0
📌 0